Clinicians share insights to shape AI support for breast cancer patients
NCT ID NCT07644845
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study asks 12 clinicians in Florida who care for women with breast cancer about gaps in emotional and mental health support. They will join virtual focus groups and fill out a short survey. The goal is to use their insights to build an AI-powered digital platform called MammoVerse that could offer emotional support, peer connection, and better healthcare engagement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could guide the development of an AI-based digital platform to improve emotional support and peer connection for breast cancer patients.
- What could go wrong
- This is a very small, early-stage study (12 clinicians) that only collects opinions, not patient data. The AI platform is not yet built, so benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Central Florida
Orlando, Florida, 32827, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?